Marc Martens
Bird & Bird
Bird & Bird
Client SatisfactionCounting many of the largest pharma and biotech companies worldwide as regular clients, Bird & Bird is equally comfortable handling cutting-edge work for innovators and generics alike. Marc Martens, who co-heads the firm's global life sciences and healthcare group, has specific expertise in biobanking, advanced therapies, clinical trials and data exclusivity disputes. More broadly, the practice has recently been particularly active in the digital health space, and has also assisted with a number of matters related to the Covid-19 pandemic. In team news, Nicolas Carbonnelle was promoted to partner in May 2022.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'Very easy to work with, very capable.'
Key clients
- Polpharma Pharmaceutical Works
- Nueraxpharma
- Teva Pharma
- Kaneka Eurogentec
- PDC*Line Pharma SA
- Terumo Europe
- Op2Lysis SAS
- CooperVision
- Essencia (bio.be)
- Novadip, MaSTherCell SA (Catalent), EMBL, Vital Strategies, UCB
- European Commission: SMART-BEAR project
- EG (formerly Eurogenerics)
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Nicolas Carbonnelle
Bird & BirdPractice head
The lawyer(s) leading their teams.
Marc Martens